What comes next for Mayo’s COVID-19 plasma program?

The New York Times is reporting this week that a group of top federal health officials have privately voiced concern about a prominent COVID-19 research program run by the Mayo Clinic. The program is testing the use of blood plasma from recovered patients to treat those who are seriously ill with the virus.

Mayo Clinic recently reported promising results, and enrollment in the program has surged. But according to the Times, Dr. Anthony Fauci and other top health officials stepped in last week to block what's known as an “emergency use authorization” for the plasma treatment.

For more, MPR News host Cathy Wurzer talked with Dr. Scott Wright, who is helping oversee the Mayo Clinic’s convalescent plasma program.

MPR News is Reader Funded

Before you keep reading, take a moment to donate to MPR News. Your financial support ensures that factual and trusted news and context remain accessible to all.